Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Aggiornamento

PDF

Salute del bambino ed esposizione alcolica

CHILDREN HEALTH AND ALCOHOL EXPOSURE

Rosanna Mancinelli

Centro Nazionale Sostanze Chimiche, Istituto Superiore di Sanità, Roma

Novembre 2011 - pagg. 565 -570

Abstract
New patterns of alcohol drinking are leading to a significant increase in alcohol damage. Epidemiological data show lowering age of first alcohol use that in Italy is close to 12 ys, and an increasing number of female drinkers. The latest evidence indicates a higher risk for female pathologies and for alcohol drinking during pregnancy with consequent foetal alcohol exposure. In the western countries, prenatal alcohol exposure is the main preventable cause of mental retardation in children. Alcohol produces negative effects on foetal development globally defined FASD (Foetal Alcohol Spectrum Disorders) and the major consequence is FAS (Foetal Alcohol Syndrome). Recent epidemiological studies show that FAS and FASD are present in Italy and are surely underestimated. Some aspects of alcohol-related problems in paediatric age are discussed in the present article together with recent perspectives in the study on new biomarkers. However, prevention is the mainstay where paediatricians may have a pivotal role in recognizing and treating alcohol disease in the newborn and in the early adolescent promptly.
Bibliografia
1. Mancinelli R, Guiducci MS. La donna e l’alcol: vulnerabilità biologica? Annali ISS 2004; 40:19-23. 2. Frezza M, Di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol level in women. The role of decreased gastric alcohol dehydrogenase activity and first pass metabolism. N Engl J Med 1990;322:95-9. 3. Parlesak A, Billinger MH, Bode C, Bode JC. Gastric alcohol dehydrogenase activity in man: influence of gender, age, alcohol consumption, and smoking in a Caucasian population. Alcohol Alcohol 2002;37:388-93. 4. Berkey CS, Willett WC, Frazier AL, et al. Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics 2010;125:1081-7. 5. Nasrallah NA, Yang TW, Bernstein IL. Long-term risk preference and suboptimal decision making following adolescent alcohol use. Proc Natl Acad Sci USA 2009;106:17600-4. 6. Fiore M, Laviola G, Aloe L, di Fausto V, Mancinelli R, Ceccanti M. Early exposure to ethanol but not red wine at the same alcohol concentration induces behavioral and brain neurotrophin alterations in young and adult mice. Neurotoxicology 2009;30:59-71. 7. Burd L, Klug MG, Li Q, Kerbeshian J, Martsolf JT. Diagnosis of fetal alcohol spectrum disorders: a validity study of the fetal alcohol syndrome checklist. Alcohol 2010;44:605-14. 8. May PA, Fiorentino D, Gossage JP, et al. Epidemiology of FASD in a province in Italy: prevalence and characteristics of children in a random sample of schools. Alcohol Clin Exp Res 2006;13:1562-75. 9. Mancinelli R, Laviola G, Ceccanti M (Eds). Special Issue. Fetal alcohol spectrum disorders (FASD): from experimental biology to the quest for treatment. Neurosci Biobehav Rev 2007;31:165-286. 10. Mancinelli R, Ceccanti M. Biomarkers in alcohol misuse: their role in the prevention and detection of thiamine deficiency. Alcohol Alcohol 2009;44:177-82. 11. Stoler JM, Huntington KS, Peterson CM, et al. The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr 1998;133:346-52 . 12. Sarkola T, Eriksson CJ, Niemelä O, Sillanaukee P, Halmesmäki E. Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin- acetaldehyde adducts in the followup of pregnant women with alcohol abuse. Acta Obstet Gynecol Scand 2000;79:359-66. 13. Zelner I, Shor S, Gareri J, et al. Universal screening for prenatal alcohol exposure: a progress report of a pilot study in the region of Grey Bruce, Ontario. Ther Drug Monit 2010; 32:305-10.

Corrispondenza: rosanna.mancinelli@iss.it